| Year |
Citation |
Score |
| 2022 |
Yamashita F, Kaieda T, Shimomura T, Kawaguchi M, Lin CY, Johnson MD, Tanaka H, Kiwaki T, Fukushima T, Kataoka H. Role of the polycystic kidney disease domain in matriptase chaperone activity and localization of hepatocyte growth factor activator inhibitor-1. The Febs Journal. PMID 35020274 DOI: 10.1111/febs.16348 |
0.373 |
|
| 2021 |
Barndt RB, Lee MJ, Huang N, Lu DD, Lee SC, Du PW, Chang CC, Tsai PB, Huang YK, Chang HM, Wang JK, Lai CH, Johnson MD, Lin CY. Targeted HAI-2 deletion causes excessive proteolysis with prolonged active prostasin and depletion of HAI-1 monomer in intestinal but not epidermal epithelial cells. Human Molecular Genetics. PMID 34089062 DOI: 10.1093/hmg/ddab150 |
0.393 |
|
| 2021 |
Lu DD, Gu Y, Li SA, Barndt RJ, Huang SM, Wang JK, Su HC, Johnson MD, Lin CY. Targeted deletion of HAI-1 increases prostasin proteolysis but decreases matriptase proteolysis in human keratinocytes. Human Cell. PMID 33486722 DOI: 10.1007/s13577-021-00488-1 |
0.402 |
|
| 2020 |
Chiu YL, Wu YY, Barndt RB, Lin YW, Sytwo HP, Cheng A, Yang K, Chan KS, Wang JK, Johnson MD, Lin CY. Differential subcellular distribution renders HAI-2 a less effective protease inhibitor than HAI-1 in the control of extracellular matriptase proteolytic activity. Genes & Diseases. 9: 1049-1061. PMID 35685459 DOI: 10.1016/j.gendis.2020.12.001 |
0.437 |
|
| 2020 |
Jia B, Thompson HA, Barndt RB, Chiu YL, Lee MJ, Lee SC, Wang JK, Tang HJ, Lin CY, Johnson MD. Mild acidity likely accelerates the physiological matriptase autoactivation process: a comparative study between spontaneous and acid-induced matriptase zymogen activation. Human Cell. PMID 32779152 DOI: 10.1007/S13577-020-00410-1 |
0.488 |
|
| 2020 |
Chang SC, Chiang CP, Lai CH, Du PA, Hung YS, Chen YH, Yang HY, Fang HY, Lee SP, Tang HJ, Wang JK, Johnson MD, Lin CY. Matriptase and prostasin proteolytic activities are differentially regulated in normal and wounded skin. Human Cell. PMID 32617892 DOI: 10.1007/S13577-020-00385-Z |
0.406 |
|
| 2020 |
Lin CY, Wang JK, Johnson MD. The spatiotemporal control of human matriptase action on its physiological substrates: a case against a direct role for matriptase proteolytic activity in profilaggrin processing and desquamation. Human Cell. PMID 32306195 DOI: 10.1007/S13577-020-00361-7 |
0.446 |
|
| 2020 |
Lin Z, Lin SY, Xie P, Lin CY, Rather GM, Bertino JR, Javanmard M. Rapid Assessment of Surface Markers on Cancer Cells Using Immuno-Magnetic Separation and Multi-frequency Impedance Cytometry for Targeted Therapy. Scientific Reports. 10: 3015. PMID 32080205 DOI: 10.1038/S41598-020-57540-7 |
0.357 |
|
| 2020 |
Tseng CC, Jia B, Barndt RB, Dai YH, Chen YH, Du PA, Wang JK, Tang HJ, Lin CY, Johnson MD. The intracellular seven amino acid motif EEGEVFL is required for matriptase vesicle sorting and translocation to the basolateral plasma membrane. Plos One. 15: e0228874. PMID 32049977 DOI: 10.1371/Journal.Pone.0228874 |
0.388 |
|
| 2019 |
Chiu YL, Wu YY, Barndt RB, Yeo YH, Lin YW, Sytwo HP, Liu HC, Xu Y, Jia B, Wang JK, Johnson MD, Lin CY. Aberrant regulation favours matriptase proteolysis in neoplastic B-cells that co-express HAI-2. Journal of Enzyme Inhibition and Medicinal Chemistry. 34: 692-702. PMID 30777474 DOI: 10.1080/14756366.2019.1577831 |
0.488 |
|
| 2018 |
Rather GM, Lin SY, Lin H, Banach-Petrosky W, Hirshfield KM, Lin CY, Johnson MD, Szekely Z, Bertino JR. Activated matriptase as a target to treat breast cancer with a drug conjugate. Oncotarget. 9: 25983-25992. PMID 29899836 DOI: 10.18632/Oncotarget.25414 |
0.385 |
|
| 2018 |
Yamamoto K, Kawaguchi M, Shimomura T, Izumi A, Konari K, Honda A, Lin CY, Johnson MD, Yamashita Y, Fukushima T, Kataoka H. Hepatocyte growth factor activator inhibitor type-2 (HAI-2)/contributes to invasive growth of oral squamous cell carcinoma cells. Oncotarget. 9: 11691-11706. PMID 29545930 DOI: 10.18632/Oncotarget.24450 |
0.446 |
|
| 2018 |
Lee SP, Kao CY, Chang SC, Chiu YL, Chen YJ, Chen MG, Chang CC, Lin YW, Chiang CP, Wang JK, Lin CY, Johnson MD. Tissue distribution and subcellular localizations determine in vivo functional relationship among prostasin, matriptase, HAI-1, and HAI-2 in human skin. Plos One. 13: e0192632. PMID 29438412 DOI: 10.1371/journal.pone.0192632 |
0.329 |
|
| 2017 |
Tseng CC, Jia B, Barndt R, Gu Y, Chen CY, Tseng IC, Su SF, Wang JK, Johnson MD, Lin CY. Matriptase shedding is closely coupled with matriptase zymogen activation and requires de novo proteolytic cleavage likely involving its own activity. Plos One. 12: e0183507. PMID 28829816 DOI: 10.1371/Journal.Pone.0183507 |
0.661 |
|
| 2017 |
Shiao F, Liu LO, Huang N, Lai YJ, Barndt RJ, Tseng CC, Wang JK, Jia B, Johnson MD, Lin CY. Selective Inhibition of Prostasin in Human Enterocytes by the Integral Membrane Kunitz-Type Serine Protease Inhibitor HAI-2. Plos One. 12: e0170944. PMID 28125689 DOI: 10.1016/S0016-5085(17)33110-4 |
0.496 |
|
| 2016 |
Su HC, Liang YA, Lai YJ, Chiu YL, Barndt RB, Shiao F, Chang HD, Lu DD, Huang N, Tseng CC, Wang JK, Lee MS, Johnson MD, Huang SM, Lin CY. Natural Endogenous Human Matriptase and Prostasin Undergo Zymogen Activation via Independent Mechanisms in an Uncoupled Manner. Plos One. 11: e0167894. PMID 27936035 DOI: 10.1371/Journal.Pone.0167894 |
0.537 |
|
| 2016 |
Kanemaru A, Yamamoto K, Kawaguchi M, Fukushima T, Lin CY, Johnson MD, Camerer E, Kataoka H. Deregulated matriptase activity in oral squamous cell carcinoma promotes the infiltration of cancer-associated fibroblasts by paracrine activation of protease-activated receptor 2. International Journal of Cancer. PMID 27615543 DOI: 10.1002/Ijc.30426 |
0.514 |
|
| 2016 |
Lai CH, Lai YJ, Chou FP, Chang HD, Tseng CC, Johnson MD, Wang JK, Lin CY. Matriptase Complexes and Prostasin Complexes with HAI-1 and HAI-2 in Human Milk: Significant Proteolysis in Lactation. Plos One. 11: e0152904. PMID 27043831 DOI: 10.1371/Journal.Pone.0152904 |
0.618 |
|
| 2016 |
Chen CY, Chen CJ, Lai CH, Wu BY, Lee SP, Johnson MD, Lin CY, Wang JK. Increased matriptase zymogen activation by UV irradiation protects keratinocyte from cell death. Journal of Dermatological Science. PMID 26996264 DOI: 10.1016/J.Jdermsci.2016.03.006 |
0.353 |
|
| 2016 |
Chen YW, Yin S, Lai YJ, Johnson MD, Lin CY. Plasminogen-dependent matriptase activation accelerates plasmin generation by differentiating primary human keratinocytes. The Journal of Investigative Dermatology. PMID 26872599 DOI: 10.1016/J.Jid.2016.01.029 |
0.623 |
|
| 2015 |
Hsu YL, Chen YW, Lin CY, Lai YC, Chen SC, Lin ZY. Variable uptake feature of focal nodular hyperplasia in Tc-99m phytate hepatic scintigraphy/single-photon emission computed tomography-A parametric analysis. The Kaohsiung Journal of Medical Sciences. 31: 621-5. PMID 26709223 DOI: 10.1016/j.kjms.2015.09.010 |
0.378 |
|
| 2015 |
Lai YJ, Chang HD, Lai H, Xu Y, Shiao F, Huang N, Li L, Lee MS, Johnson MD, Wang JK, Lin CY. N-Glycan Branching Affects the Subcellular Distribution of and Inhibition of Matriptase by HAI-2/Placental Bikunin. Plos One. 10: e0132163. PMID 26171609 DOI: 10.1371/Journal.Pone.0132163 |
0.397 |
|
| 2015 |
Najy AJ, Dyson G, Jena BP, Lin CY, Kim HC. Matriptase Activation and Shedding through PDGF-D-mediated Extracellular Acidosis. American Journal of Physiology. Cell Physiology. ajpcell.00043.2015. PMID 26157007 DOI: 10.1152/Ajpcell.00043.2015 |
0.396 |
|
| 2015 |
Lin CY, Hsieh HY, Pitt WG, Huang CY, Tseng IC, Yeh CK, Wei KC, Liu HL. Focused ultrasound-induced blood-brain barrier opening for non-viral, non-invasive, and targeted gene delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 212: 1-9. PMID 26071631 DOI: 10.1016/j.jconrel.2015.06.010 |
0.532 |
|
| 2015 |
Chang YL, Liu CT, Chu HL, Chen YW, Lin CY. Incidental Finding of Urinary Bladder Retention on the 99mTc-Labeled Red Blood Cells Subcutaneous Radionuclide Venography. Clinical Nuclear Medicine. PMID 26018701 DOI: 10.1097/RLU.0000000000000820 |
0.396 |
|
| 2015 |
Kawaguchi M, Kanemaru A, Sawaguchi A, Yamamoto K, Baba T, Lin CY, Johnson MD, Fukushima T, Kataoka H. Hepatocyte Growth Factor Activator Inhibitor Type 1 Maintains the Assembly of Keratin into Desmosomes in Keratinocytes by Regulating Protease-Activated Receptor 2-Dependent p38 Signaling. The American Journal of Pathology. 185: 1610-23. PMID 25842366 DOI: 10.1016/J.Ajpath.2015.02.009 |
0.494 |
|
| 2015 |
Chang HH, Xu Y, Lai H, Yang X, Tseng CC, Lai YJ, Pan Y, Zhou E, Johnson MD, Wang JK, Lin CY. Differential subcellular localization renders HAI-2 a matriptase inhibitor in breast cancer cells but not in mammary epithelial cells. Plos One. 10: e0120489. PMID 25786220 DOI: 10.1371/Journal.Pone.0120489 |
0.482 |
|
| 2014 |
Chang CC, Tu HP, Chen YW, Lin CY, Hou MF. Tumour and lymph node uptakes on dual-phased 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography correlate with prognostic parameters in breast cancer. The Journal of International Medical Research. 42: 1209-21. PMID 25339454 DOI: 10.1177/0300060514549785 |
0.377 |
|
| 2014 |
Wang JK, Teng IJ, Lo TJ, Moore S, Yeo YH, Teng YC, Kaul M, Chen CC, Zuo AH, Chou FP, Yang X, Tseng IC, Johnson MD, Lin CY. Matriptase autoactivation is tightly regulated by the cellular chemical environments. Plos One. 9: e93899. PMID 24705933 DOI: 10.1371/Journal.Pone.0093899 |
0.695 |
|
| 2014 |
Chu LL, Xu Y, Yang JR, Hu YA, Chang HH, Lai HY, Tseng CC, Wang HY, Johnson MD, Wang JK, Lin CY. Human cancer cells retain modest levels of enzymatically active matriptase only in extracellular milieu following induction of zymogen activation. Plos One. 9: e92244. PMID 24663123 DOI: 10.1371/Journal.Pone.0092244 |
0.532 |
|
| 2014 |
Ye J, Kawaguchi M, Haruyama Y, Kanemaru A, Fukushima T, Yamamoto K, Lin CY, Kataoka H. Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model. Cancer Science. 105: 44-51. PMID 24147538 DOI: 10.1111/Cas.12306 |
0.502 |
|
| 2014 |
Tsai CH, Teng CH, Tu YT, Cheng TS, Wu SR, Ko CJ, Shyu HY, Lan SW, Huang HP, Tzeng SF, Johnson MD, Lin CY, Hsiao PW, Lee MS. HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase. Oncogene. 33: 4643-52. PMID 24121274 DOI: 10.1038/Onc.2013.412 |
0.313 |
|
| 2014 |
Wu BY, Lee SP, Hsiao HC, Chiu H, Chen CY, Yeo YH, Lee HS, Chen YW, Kaul M, Kataoka H, Johnson MD, Wang JK, Lin CY. Matriptase expression and zymogen activation in human pilosebaceous unit. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 62: 50-9. PMID 24004857 DOI: 10.1369/0022155413505599 |
0.613 |
|
| 2014 |
Chen YW, Wang JK, Chou FP, Wu BY, Hsiao HC, Chiu H, Xu Z, Baksh AN, Shi G, Kaul M, Barndt R, Shanmugam VK, Johnson MD, Lin CY. Matriptase regulates proliferation and early, but not terminal, differentiation of human keratinocytes. The Journal of Investigative Dermatology. 134: 405-14. PMID 23900022 DOI: 10.1038/Jid.2013.320 |
0.679 |
|
| 2013 |
Chou FP, Chen YW, Zhao XF, Xu-Monette ZY, Young KH, Gartenhaus RB, Wang JK, Kataoka H, Zuo AH, Barndt RJ, Johnson M, Lin CY. Imbalanced matriptase pericellular proteolysis contributes to the pathogenesis of malignant B-cell lymphomas. The American Journal of Pathology. 183: 1306-17. PMID 24070417 DOI: 10.1016/j.ajpath.2013.06.024 |
0.703 |
|
| 2013 |
Lin CY, Huo C, Kuo LK, Hiipakka RA, Jones RB, Lin HP, Hung Y, Su LC, Tseng JC, Kuo YY, Wang YL, Fukui Y, Kao YH, Kokontis JM, Yeh CC, et al. Cholestane-3β, 5α, 6β-triol suppresses proliferation, migration, and invasion of human prostate cancer cells. Plos One. 8: e65734. PMID 23785446 DOI: 10.1371/journal.pone.0065734 |
0.544 |
|
| 2013 |
Chen YW, Xu Z, Baksh AN, Wang JK, Chen CY, Swanson R, Olson ST, Kataoka H, Johnson MD, Lin CY. Antithrombin regulates matriptase activity involved in plasmin generation, syndecan shedding, and HGF activation in keratinocytes. Plos One. 8: e62826. PMID 23675430 DOI: 10.1371/Journal.Pone.0062826 |
0.652 |
|
| 2013 |
Friis S, Uzzun Sales K, Godiksen S, Peters DE, Lin CY, Vogel LK, Bugge TH. A matriptase-prostasin reciprocal zymogen activation complex with unique features: prostasin as a non-enzymatic co-factor for matriptase activation. The Journal of Biological Chemistry. 288: 19028-39. PMID 23673661 DOI: 10.1074/Jbc.M113.469932 |
0.484 |
|
| 2013 |
Uen YH, Lin KY, Sun DP, Liao CC, Hsieh MS, Huang YK, Chen YW, Huang PH, Chen WJ, Tai CC, Lee KW, Chen YC, Lin CY. Comparative proteomics, network analysis and post-translational modification identification reveal differential profiles of plasma Con A-bound glycoprotein biomarkers in gastric cancer. Journal of Proteomics. 83: 197-213. PMID 23541716 DOI: 10.1016/j.jprot.2013.03.007 |
0.45 |
|
| 2013 |
Lin CY, Chen YW, Chang CC, Yang WC, Huang CJ, Hou MF. Bone metastasis versus bone marrow metastasis? Integration of diagnosis by (18)F-fluorodeoxyglucose positron emission/computed tomography in advanced malignancy with super bone scan: two case reports and literature review. The Kaohsiung Journal of Medical Sciences. 29: 229-33. PMID 23541269 DOI: 10.1016/j.kjms.2012.08.038 |
0.364 |
|
| 2013 |
Larsen BR, Steffensen SD, Nielsen NV, Friis S, Godiksen S, Bornholdt J, Soendergaard C, Nonboe AW, Andersen MN, Poulsen SS, Szabo R, Bugge TH, Lin CY, Skovbjerg H, Jensen JK, et al. Hepatocyte growth factor activator inhibitor-2 prevents shedding of matriptase. Experimental Cell Research. 319: 918-29. PMID 23333561 DOI: 10.1016/J.Yexcr.2013.01.008 |
0.42 |
|
| 2012 |
Kohama K, Kawaguchi M, Fukushima T, Lin CY, Kataoka H. Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells. Human Cell. 25: 100-10. PMID 23248048 DOI: 10.1007/s13577-012-0055-2 |
0.425 |
|
| 2012 |
Chang CC, Cho SF, Chen YW, Tu HP, Lin CY, Chang CS. SUV on dual-phase FDG PET/CT correlates with the Ki-67 proliferation index in patients with newly diagnosed non-Hodgkin lymphoma. Clinical Nuclear Medicine. 37: e189-95. PMID 22785526 DOI: 10.1097/RLU.0b013e318251e16e |
0.378 |
|
| 2012 |
Baba T, Kawaguchi M, Fukushima T, Sato Y, Orikawa H, Yorita K, Tanaka H, Lin CY, Sakoda S, Kataoka H. Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness. The Journal of Pathology. 228: 181-92. PMID 22262311 DOI: 10.1002/path.3993 |
0.305 |
|
| 2012 |
Xu H, Xu Z, Tseng IC, Chou FP, Chen YW, Wang JK, Johnson MD, Kataoka H, Lin CY. Mechanisms for the control of matriptase activity in the absence of sufficient HAI-1. American Journal of Physiology. Cell Physiology. 302: C453-62. PMID 22031598 DOI: 10.1152/Ajpcell.00344.2011 |
0.793 |
|
| 2012 |
Kundu N, Campbell P, Hampton B, Lin CY, Ma X, Ambulos N, Zhao XF, Goloubeva O, Holt D, Fulton AM. Antimetastatic activity isolated from Colocasia esculenta (taro). Anti-Cancer Drugs. 23: 200-11. PMID 21934603 DOI: 10.1097/Cad.0B013E32834B85E8 |
0.419 |
|
| 2012 |
Scharadin TM, Lin C, Eckert RL. TIG3 Is a Multifunctional Regulator of Keratinocyte Differentiation and Survival Journal of Medical Sciences. 32: 157-164. DOI: 10.6136/Jms.2012.32(4).157 |
0.409 |
|
| 2012 |
Chen Y, Eckert RD, Johnson MD, Lin C. The Transmembrane Serine Protease Matriptase: Implications for Cellular Biology and Human Diseases Journal of Medical Sciences. 32: 97-108. DOI: 10.6136/Jms.2012.32(3).097 |
0.542 |
|
| 2011 |
Xu Z, Chen YW, Battu A, Wilder P, Weber D, Yu W, Mackerell AD, Chen LM, Chai KX, Johnson MD, Lin CY. Targeting zymogen activation to control the matriptase-prostasin proteolytic cascade. Journal of Medicinal Chemistry. 54: 7567-78. PMID 21966950 DOI: 10.1021/Jm200920S |
0.61 |
|
| 2011 |
Yuan S, Yu SL, Chen HY, Hsu YC, Su KY, Chen HW, Chen CY, Yu CJ, Shih JY, Chang YL, Cheng CL, Hsu CP, Hsia JY, Lin CY, Wu G, et al. Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 3435-42. PMID 21810691 DOI: 10.1200/JCO.2011.35.3979 |
0.44 |
|
| 2011 |
Chou FP, Xu H, Lee MS, Chen YW, Richards OX, Swanson R, Olson ST, Johnson MD, Lin CY. Matriptase is inhibited by extravascular antithrombin in epithelial cells but not in most carcinoma cells. American Journal of Physiology. Cell Physiology. 301: C1093-103. PMID 21795523 DOI: 10.1152/Ajpcell.00122.2011 |
0.721 |
|
| 2011 |
Chen YW, Lin CY, Hou PN, Lee CS, Hou MF, Tsai EM. Whole-body FDG PET/CT in diagnosis of internal mammary nodal metastasis of ovarian carcinosarcoma. Clinical Nuclear Medicine. 36: 460-1. PMID 21552025 DOI: 10.1097/RLU.0b013e31820aa165 |
0.38 |
|
| 2011 |
Friis S, Godiksen S, Bornholdt J, Selzer-Plon J, Rasmussen HB, Bugge TH, Lin CY, Vogel LK. Transport via the transcytotic pathway makes prostasin available as a substrate for matriptase. The Journal of Biological Chemistry. 286: 5793-802. PMID 21148558 DOI: 10.1074/Jbc.M110.186874 |
0.363 |
|
| 2011 |
Chen CJ, Wu BY, Tsao PI, Chen CY, Wu MH, Chan YL, Lee HS, Johnson MD, Eckert RL, Chen YW, Chou F, Wang JK, Lin CY. Increased matriptase zymogen activation in inflammatory skin disorders. American Journal of Physiology. Cell Physiology. 300: C406-15. PMID 21123732 DOI: 10.1152/Ajpcell.00403.2010 |
0.693 |
|
| 2011 |
Wu S, Teng C, Tsai C, Tu Y, Cheng T, Shyu H, Ko C, Lan S, Huang H, Lin C, Hsiao P, Lee M. Abstract 1413: Hepatocyte growth factor activator inhibitor-2 inhibits prostate cancer cell migration and invasion Cancer Research. 71: 1413-1413. DOI: 10.1158/1538-7445.Am2011-1413 |
0.408 |
|
| 2010 |
Wu SR, Cheng TS, Chen WC, Shyu HY, Ko CJ, Huang HP, Teng CH, Lin CH, Johnson MD, Lin CY, Lee MS. Matriptase is involved in ErbB-2-induced prostate cancer cell invasion. The American Journal of Pathology. 177: 3145-58. PMID 20971737 DOI: 10.2353/Ajpath.2010.100228 |
0.507 |
|
| 2010 |
Chen YW, Wang JK, Chou FP, Chen CY, Rorke EA, Chen LM, Chai KX, Eckert RL, Johnson MD, Lin CY. Regulation of the matriptase-prostasin cell surface proteolytic cascade by hepatocyte growth factor activator inhibitor-1 during epidermal differentiation. The Journal of Biological Chemistry. 285: 31755-62. PMID 20696767 DOI: 10.1074/Jbc.M110.150367 |
0.745 |
|
| 2010 |
Jiang H, Jans R, Xu W, Rorke EA, Lin CY, Chen YW, Fang S, Zhong Y, Eckert RL. Type I transglutaminase accumulation in the endoplasmic reticulum may be an underlying cause of autosomal recessive congenital ichthyosis. The Journal of Biological Chemistry. 285: 31634-46. PMID 20663883 DOI: 10.1074/Jbc.M110.128645 |
0.425 |
|
| 2010 |
Chen YW, Lee MS, Lucht A, Chou FP, Huang W, Havighurst TC, Kim K, Wang JK, Antalis TM, Johnson MD, Lin CY. TMPRSS2, a serine protease expressed in the prostate on the apical surface of luminal epithelial cells and released into semen in prostasomes, is misregulated in prostate cancer cells. The American Journal of Pathology. 176: 2986-96. PMID 20382709 DOI: 10.2353/Ajpath.2010.090665 |
0.675 |
|
| 2010 |
Tseng IC, Xu H, Chou FP, Li G, Vazzano AP, Kao JP, Johnson MD, Lin CY. Matriptase activation, an early cellular response to acidosis. The Journal of Biological Chemistry. 285: 3261-70. PMID 19940125 DOI: 10.1074/Jbc.M109.055640 |
0.755 |
|
| 2010 |
Chen M, Chen LM, Lin CY, Chai KX. Hepsin activates prostasin and cleaves the extracellular domain of the epidermal growth factor receptor. Molecular and Cellular Biochemistry. 337: 259-66. PMID 19911255 DOI: 10.1007/S11010-009-0307-Y |
0.403 |
|
| 2010 |
Bertino JR, Lin S, Lin C. Abstract 2596: Targeted delivery of doxorubicin conjugated with anti-matriptase antibody to treat multiple myeloma Cancer Research. 70: 2596-2596. DOI: 10.1158/1538-7445.Am10-2596 |
0.379 |
|
| 2009 |
Wang JK, Lee MS, Tseng IC, Chou FP, Chen YW, Fulton A, Lee HS, Chen CJ, Johnson MD, Lin CY. Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition. American Journal of Physiology. Cell Physiology. 297: C459-70. PMID 19535514 DOI: 10.1152/Ajpcell.00201.2009 |
0.79 |
|
| 2009 |
Warren M, Twohig M, Pier T, Eickhoff J, Lin CY, Jarrard D, Huang W. Protein expression of matriptase and its cognate inhibitor HAI-1 in human prostate cancer: a tissue microarray and automated quantitative analysis. Applied Immunohistochemistry & Molecular Morphology : Aimm / Official Publication of the Society For Applied Immunohistochemistry. 17: 23-30. PMID 18813126 DOI: 10.1097/Pai.0B013E31817C3334 |
0.382 |
|
| 2009 |
Choi JC, Hausner SH, Gagnon MKJ, Kukis DL, Holland JP, Lewis JS, Lin C, Johnson MD, Sutcliffe JL. Abstract A227: Positron emission tomographic (PET) imaging of activated matriptase, a marker for cancer progression Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-A227 |
0.324 |
|
| 2008 |
Szabo R, Hobson JP, List K, Molinolo A, Lin CY, Bugge TH. Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity. The Journal of Biological Chemistry. 283: 29495-504. PMID 18713750 DOI: 10.1074/jbc.M801970200 |
0.434 |
|
| 2008 |
Tseng IC, Chou FP, Su SF, Oberst M, Madayiputhiya N, Lee MS, Wang JK, Sloane DE, Johnson M, Lin CY. Purification from human milk of matriptase complexes with secreted serpins: mechanism for inhibition of matriptase other than HAI-1. American Journal of Physiology. Cell Physiology. 295: C423-31. PMID 18550704 DOI: 10.1152/Ajpcell.00164.2008 |
0.763 |
|
| 2008 |
Chen M, Chen LM, Lin CY, Chai KX. The epidermal growth factor receptor (EGFR) is proteolytically modified by the Matriptase-Prostasin serine protease cascade in cultured epithelial cells. Biochimica Et Biophysica Acta. 1783: 896-903. PMID 18054338 DOI: 10.1016/J.Bbamcr.2007.10.019 |
0.414 |
|
| 2008 |
Lin CY, Tseng IC, Chou FP, Su SF, Chen YW, Johnson MD, Dickson RB. Zymogen activation, inhibition, and ectodomain shedding of matriptase. Frontiers in Bioscience : a Journal and Virtual Library. 13: 621-35. PMID 17981575 |
0.743 |
|
| 2007 |
Chen M, Fu YY, Lin CY, Chen LM, Chai KX. Prostasin induces protease-dependent and independent molecular changes in the human prostate carcinoma cell line PC-3. Biochimica Et Biophysica Acta. 1773: 1133-40. PMID 17532063 DOI: 10.1016/J.Bbamcr.2007.04.013 |
0.449 |
|
| 2007 |
Lee MS, Tseng IC, Wang Y, Kiyomiya K, Johnson MD, Dickson RB, Lin CY. Autoactivation of matriptase in vitro: requirement for biomembrane and LDL receptor domain. American Journal of Physiology. Cell Physiology. 293: C95-105. PMID 17344310 DOI: 10.1152/Ajpcell.00611.2006 |
0.705 |
|
| 2006 |
Jin X, Yagi M, Akiyama N, Hirosaki T, Higashi S, Lin CY, Dickson RB, Kitamura H, Miyazaki K. Matriptase activates stromelysin (MMP-3) and promotes tumor growth and angiogenesis. Cancer Science. 97: 1327-34. PMID 16999819 DOI: 10.1111/J.1349-7006.2006.00328.X |
0.411 |
|
| 2006 |
Netzel-Arnett S, Currie BM, Szabo R, Lin CY, Chen LM, Chai KX, Antalis TM, Bugge TH, List K. Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation. The Journal of Biological Chemistry. 281: 32941-5. PMID 16980306 DOI: 10.1074/Jbc.C600208200 |
0.355 |
|
| 2006 |
Saleem M, Adhami VM, Zhong W, Longley BJ, Lin CY, Dickson RB, Reagan-Shaw S, Jarrard DF, Mukhtar H. A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 217-27. PMID 16492908 DOI: 10.1158/1055-9965.Epi-05-0737 |
0.302 |
|
| 2006 |
Kiyomiya K, Lee MS, Tseng IC, Zuo H, Barndt RJ, Johnson MD, Dickson RB, Lin CY. Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells. American Journal of Physiology. Cell Physiology. 291: C40-9. PMID 16467405 DOI: 10.1152/Ajpcell.00351.2005 |
0.696 |
|
| 2006 |
Ito Y, Akinaga A, Yamanaka K, Nakagawa T, Kondo A, Dickson RB, Lin CY, Miyauchi A, Taniguchi N, Miyoshi E. Co-expression of matriptase and N-acetylglucosaminyltransferase V in thyroid cancer tissues--its possible role in prolonged stability in vivo by aberrant glycosylation. Glycobiology. 16: 368-74. PMID 16464868 DOI: 10.1093/Glycob/Cwj084 |
0.317 |
|
| 2006 |
Ahmed S, Jin X, Yagi M, Yasuda C, Sato Y, Higashi S, Lin CY, Dickson RB, Miyazaki K. Identification of membrane-bound serine proteinase matriptase as processing enzyme of insulin-like growth factor binding protein-related protein-1 (IGFBP-rP1/angiomodulin/mac25). The Febs Journal. 273: 615-27. PMID 16420484 DOI: 10.1111/J.1742-4658.2005.05094.X |
0.428 |
|
| 2005 |
Siddiqui SF, Pawelek J, Handerson T, Lin CY, Dickson RB, Rimm DL, Camp RL. Coexpression of β1,6-N-acetylglucosaminyltransferase V glycoprotein substrates defines aggressive breast cancers with poor outcome Cancer Epidemiology Biomarkers and Prevention. 14: 2517-2523. PMID 16284372 DOI: 10.1158/1055-9965.Epi-05-0464 |
0.334 |
|
| 2005 |
Jin X, Hirosaki T, Lin CY, Dickson RB, Higashi S, Kitamura H, Miyazaki K. Production of soluble matriptase by human cancer cell lines and cell surface activation of its zymogen by trypsin. Journal of Cellular Biochemistry. 95: 632-47. PMID 15832373 DOI: 10.1002/Jcb.20418 |
0.445 |
|
| 2005 |
Oberst MD, Chen LY, Kiyomiya K, Williams CA, Lee MS, Johnson MD, Dickson RB, Lin CY. HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease. American Journal of Physiology. Cell Physiology. 289: C462-70. PMID 15800053 DOI: 10.1152/Ajpcell.00076.2005 |
0.528 |
|
| 2005 |
Lee MS, Kiyomiya K, Benaud C, Dickson RB, Lin CY. Simultaneous activation and hepatocyte growth factor activator inhibitor 1-mediated inhibition of matriptase induced at activation foci in human mammary epithelial cells. American Journal of Physiology. Cell Physiology. 288: C932-41. PMID 15590895 DOI: 10.1152/Ajpcell.00497.2004 |
0.518 |
|
| 2004 |
Hung RJ, Hsu IaW, Dreiling JL, Lee MJ, Williams CA, Oberst MD, Dickson RB, Lin CY. Assembly of adherens junctions is required for sphingosine 1-phosphate-induced matriptase accumulation and activation at mammary epithelial cell-cell contacts. American Journal of Physiology. Cell Physiology. 286: C1159-69. PMID 15075215 DOI: 10.1152/Ajpcell.00400.2003 |
0.445 |
|
| 2004 |
Suzuki M, Kobayashi H, Kanayama N, Saga Y, Suzuki M, Lin CY, Dickson RB, Terao T. Inhibition of tumor invasion by genomic down-regulation of matriptase through suppression of activation of receptor-bound pro-urokinase. The Journal of Biological Chemistry. 279: 14899-908. PMID 14747469 DOI: 10.1074/Jbc.M313130200 |
0.443 |
|
| 2003 |
Oberst MD, Singh B, Ozdemirli M, Dickson RB, Johnson MD, Lin CY. Characterization of matriptase expression in normal human tissues. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 51: 1017-25. PMID 12871983 DOI: 10.1177/002215540305100805 |
0.342 |
|
| 2003 |
Johnson MD, Oberst MD, Lin CY, Dickson RB. Possible role of matriptase in the diagnosis of ovarian cancer. Expert Review of Molecular Diagnostics. 3: 331-8. PMID 12779007 DOI: 10.1586/14737159.3.3.331 |
0.352 |
|
| 2003 |
Oberst MD, Williams CA, Dickson RB, Johnson MD, Lin CY. The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor. The Journal of Biological Chemistry. 278: 26773-9. PMID 12738778 DOI: 10.1074/Jbc.M304282200 |
0.433 |
|
| 2002 |
Benaud CM, Oberst M, Dickson RB, Lin CY. Deregulated activation of matriptase in breast cancer cells. Clinical & Experimental Metastasis. 19: 639-49. PMID 12498394 DOI: 10.1023/A:1020985632550 |
0.452 |
|
| 2002 |
Oberst MD, Johnson MD, Dickson RB, Lin CY, Singh B, Stewart M, Williams A, al-Nafussi A, Smyth JF, Gabra H, Sellar GC. Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 8: 1101-7. PMID 11948120 |
0.323 |
|
| 2002 |
Benaud C, Oberst M, Hobson JP, Spiegel S, Dickson RB, Lin CY. Sphingosine 1-phosphate, present in serum-derived lipoproteins, activates matriptase. The Journal of Biological Chemistry. 277: 10539-46. PMID 11792696 DOI: 10.1074/Jbc.M109064200 |
0.406 |
|
| 2001 |
Enyedy IJ, Lee SL, Kuo AH, Dickson RB, Lin CY, Wang S. Structure-based approach for the discovery of bis-benzamidines as novel inhibitors of matriptase Journal of Medicinal Chemistry. 44: 1349-1355. PMID 11311057 DOI: 10.1021/Jm000395X |
0.355 |
|
| 2001 |
Oberst M, Anders J, Xie B, Singh B, Ossandon M, Johnson M, Dickson RB, Lin CY. Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo. The American Journal of Pathology. 158: 1301-11. PMID 11290548 DOI: 10.1016/S0002-9440(10)64081-3 |
0.405 |
|
| 2001 |
Benaud C, Dickson RB, Lin CY. Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor. European Journal of Biochemistry. 268: 1439-47. PMID 11231297 DOI: 10.1046/J.1432-1327.2001.02016.X |
0.52 |
|
| 2001 |
Lee SL, Dickson RB, Lin CY. Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. The Journal of Biological Chemistry. 275: 36720-5. PMID 10962009 DOI: 10.1074/Jbc.M007802200 |
0.476 |
|
| 1999 |
Lin CY, Anders J, Johnson M, Dickson RB. Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk. The Journal of Biological Chemistry. 274: 18237-42. PMID 10373425 DOI: 10.1074/Jbc.274.26.18237 |
0.441 |
|
| 1999 |
Lin CY, Anders J, Johnson M, Sang QA, Dickson RB. Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity Journal of Biological Chemistry. 274: 18231-18236. PMID 10373424 DOI: 10.1074/Jbc.274.26.18231 |
0.423 |
|
| 1997 |
Lin CY, Wang JK, Torri J, Dou L, Sang QA, Dickson RB. Characterization of a novel, membrane-bound, 80-kDa matrix-degrading protease from human breast cancer cells: Monoclonal antibody production, isolation, and localization Journal of Biological Chemistry. 272: 9147-9152. PMID 9083044 DOI: 10.1074/Jbc.272.14.9147 |
0.383 |
|
| Show low-probability matches. |